News

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Media Contact

Stephen Schultz
VP Investor Relations (U.S.)
T: 917-280-2424 / 401 500 6570
sschultz@gwpharm.com
 

Recent Press Releases

Apr 06, 2000
The first clinical trials of cannabis-based medicines involving patients suffering from MS, spinal cord injury and other forms of severe pain and spasticity have been given permission to proceed by the UK medical au
Nov 16, 1999
GW Pharmaceuticals, the company licensed by the UK Home Office to undertake a pharmaceutical research and development programme to develop prescription cannabis-based medicines, has commenced its clinical programme.
Jun 10, 1999
The Canadian Government is considering a proposal from GW Pharmaceuticals to investigate the uses of non-smoked marijuana as a medicine.
Jan 05, 1999
The first harvest of cannabis plants is now underway at GW Pharmaceuticals, the company licensed by the Home Office to conduct a unique pharmaceutical research and development programme into the medicinal uses of ca
Nov 11, 1998
The first pictures were released today by GW Pharmaceuticals, the company licensed by the Home Office to conduct a unique pharmaceutical research and development programme into the medicinal uses of cannabis.
Jul 23, 1998
Details have been disclosed of the collaboration between GW Pharmaceuticals - the British Company licensed by the Home Office to conduct research into the medicinal uses of cannabis - and Dutch medicinal cannabis pl
Jun 11, 1998
The Home Office has issued a licence for a British pharmaceuticals company to investigate the uses of cannabis as a medicine.

Pages